Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03539133 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Systemic Organ Communication in STEMI

Study acronym: SYSTEMI
StatusRecruiting
PhaseNot specified
Started2017-10-18
View on ClinicalTrials.gov ↗

Amendment history

2026-01-20
Study Status, Outcome Measures v4
Primary completion date2023-06→2030-06
Completion date2023-06→2030-06
Secondary endpoints5 to 3 entries
PatencyAll ratecause mortaltiy leftMACCE Re-Hospitalisation ventriculardue enddiastolicto volumeheart index (LVEDVi) Ejection fraction (%) stroke volume Restenosis ratefailure
Primary endpoints2 to 4 entries
MACCELeft-ventricular (cardiovascularfunction Left-ventricular death,remodeling Myocardial non-fataltexture Patency stroke or myocardial infarction) Rehospitalization due to heart failurerate
2022-05-04
Study Identification, Study Status, Sponsor/Collaborators, Study Description, Outcome Measures, Contacts/Locations v3
Lead sponsorKlinik für Kardiologie, Pneumologie und Angiologie→Heinrich-Heine University, Duesseldorf
Secondary endpoints8 to 5 entries
left ventricular enddistolicenddiastolic volume index (LVEDVi) by MRI left ventricular enddistolic volume index (LVEDVi) by ECHO Ejection fraction (%) stroke volume
Primary endpoints1 to 2 entries
MajorMACCE adverse(cardiovascular cardiacdeath, eventsnon-fatal stroke or myocardial infarction) Rehospitalization due to heart failure
Study sitescontacts updated at 1 of 1 site
Study title-22 characters
ST-segmentSystemic ElevationOrgan MyocardialCommunication Infarctionin Clinical PathwaySTEMI
2019-08-06
Study Status v2
Re-verified, no change to tracked fields
2018-05-28
Study Status, Outcome Measures v1
Secondary endpoints6 to 8 entries
Ejection fraction (%) stroke volume
2018-05-25
Original filing
Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality. Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.
Trial Details
NCT Number NCT03539133
Lead Sponsor Heinrich-Heine University, Duesseldorf
Conditions ST-segment Elevation Myocardial Infarction (STEMI)
Enrollment 1,000 participants
Start Date 2017-10-18
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-22